ClinicalTrials.Veeva

Menu

Fluorescence Guided Minimally-Invasive Resection Of Abdominal Paragangliomas Using Indocyanine Green

L

Leiden University Medical Center (LUMC)

Status

Enrolling

Conditions

Paraganglioma

Treatments

Drug: Fluorescence guided identification using indocyanine green

Study type

Observational

Funder types

Other

Identifiers

NCT06155734
nWMO_GLL_1

Details and patient eligibility

About

This study is exploring whether it's possible to detect paragangliomas (a rare type of tumor) during minimally invasive surgery by using a technique called near-infrared fluorescence imaging, guided by a substance called indocyanine green (ICG). The goal is to see if this method can help surgeons identify and treat paragangliomas more accurately and during minimally invasive procedures.

Enrollment

6 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with abdominal paraganglioma and underwent minimally-invasive surgical resection

Exclusion criteria

  • Open surgical procedures

Trial design

6 participants in 1 patient group

Retrospective intervention cohort
Treatment:
Drug: Fluorescence guided identification using indocyanine green

Trial contacts and locations

1

Loading...

Central trial contact

Martijn van Dam, MD; Alexander L. Vahrmeijer, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems